世界の点眼薬市場:データ、分析、予測(~2024)...市場調査レポートについてご紹介

【英文タイトル】Ophthalmic Drugs; Data, Analysis and Forecasts to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Executive Summary

1.1 Ophthalmic Drugs Market Review

1.2 Chapter Breakdown

1.3 Research and Analysis Methods

2. Causes and Treatments of Ophthalmic Disorders

2.1 Human Eye

2.2 Structure of Human Eye

2.3 Major Global Causes of Blindness & Vision Impairment

2.3.1 Primary Causes of Blindness

2.3.2 Primary Causes of Visual Impairment

2.3.3 Geographic Breakdown of Global Blindness and Vision Impairment

2.3.4 Primary Factors Contributing to Visual Impairment

2.4 The Most Common Type of Eye Disorders

2.4.1 Cataracts

2.4.2 Glaucoma

2.4.3 Retinal Detachment

2.4.4 Ophthalmic Allergies

2.4.5 Ophthalmic Inflammatory Disorders

2.4.6 Ophthalmic Infections

2.4.7 Diabetic Retinopathy/Diabetic Mellitus

2.4.8 Dry Eye

2.4.9 Age-related Macular Degeneration

3. Ophthalmology Pharmaceutical Market & Forecast

3.1 Major Trends and Issues

3.2 Global Ophthalmology Pharmaceuticals Market 2014-2024

4. Anti-Glaucoma Market 2014-2024

4.1 Types of Glaucoma Eye Drops

4.2 Major Trends and Issues

4.3 Market Size and Forecast

4.4 Major Drugs & Forecast

4.4.1 Xalatan/Xalacom

4.4.2 Lumigan

4.4.3 Cosopt/Trusopt

4.4.4 Alphagan P, Alphagan and Combigan

4.4.5 Travatan

4.4.6 Azopt

5. Ophthalmic Anti-Allergy/Inflammation/Infective Market 2014-2024

5.1 Major Trends and Issues

5.2 Market Size and Forecast

5.3 Major Drugs and Forecast

5.3.1 Patanol

5.3.2 Vigamox/Vegamox

5.3.3 TobraDex

5.3.4 Pataday

5.3.5 Cravit

5.3.6 Xibrom/Bromday/Bromfenac

6. Retinal Disorders Market 2014-2024

6.1 Major Trends and Issues

6.2 Market Size and Forecast

6.3 Major Drugs and Forecast

6.3.1 Lucentis

6.3.2 Eylea

7. Dry Eye Market 2014-2024

7.1 Major Trends and Issues

7.2 Market Size and Forecast

7.3 Major Drugs and Forecast

7.3.1 Restasis

7.3.2 Hyalein

8. Regional Landscape

8.1 The US Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.2 The UK Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.3 The French Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.4 The German Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.5 The Spanish Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.6 The Italian Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.7 The Japanese Ophthalmic Pharmaceutical Drugs Market 2013-2024

8.8 The ROW Ophthalmic Pharmaceutical Drugs Market 2013-2024

9. Ophthalmology R & D Pipeline

9.1 Ophthalmology Drug R&D Pipeline for Glaucoma

9.2 Ophthalmology Drug R&D Pipeline for Anti-Infectives

9.3 Ophthalmology Drug R&D Pipeline for Anti-Inflammatory Agents

9.4 Ophthalmology Drug R&D Pipeline for Dry Eye

9.5 Gene Therapy in Ophthalmology – Ongoing Clinical Trial Details

10. Leading Companies

10.1 Alcon

10.2 Allergan

10.3 Argentis Pharmaceuticals LLC

10.4 Bausch & Lomb

10.5 Bayer Healthcare Pharmaceuticals

10.6 Eagle Vision Inc.

10.7 Eyegate Pharmaceuticals

10.8 Merck & Co

10.9 Novagali Pharma

10.10 Oasis Medical Inc.

10.11 Pfizer

10.12 Regeneron Pharmaceuticals Inc.

10.13 Resolvyx Pharmaceuticals Inc.

10.14 Roche

10.15 Santen Pharmaceutical Co Ltd

11. Expert Opinion

11.1 Dr David Sullivan, Associate Professor at Harvard Medical School

11.2 Dr Sonja Prager, Head of Diabetic Retinopathy Research Group, Vienna


【レポート販売概要】

■ タイトル:世界の点眼薬市場:データ、分析、予測(~2024)
■ 英文:Ophthalmic Drugs; Data, Analysis and Forecasts to 2024
■ 発行日:2014年3月4日
■ 調査会社:GMR Data
■ 商品コード:GMR403251
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。